{"id":"placebo-and-celecoxib","safety":{"commonSideEffects":[{"rate":"15","effect":"Headache"},{"rate":"11","effect":"Dyspepsia"},{"rate":"8","effect":"Abdominal pain"},{"rate":"5","effect":"Diarrhea"},{"rate":"7","effect":"Nausea"},{"rate":null,"effect":"Cardiovascular events (myocardial infarction, stroke)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Celecoxib is a selective COX-2 inhibitor that preferentially blocks COX-2 over COX-1, thereby reducing inflammatory prostaglandins while theoretically sparing the protective prostaglandins produced by COX-1 in the gastrointestinal tract. This selectivity was designed to provide anti-inflammatory and analgesic effects with a potentially improved gastrointestinal safety profile compared to non-selective NSAIDs. The placebo arm in this context serves as a control comparator in clinical trials.","oneSentence":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:42.121Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Osteoarthritis"},{"name":"Acute pain"},{"name":"Primary dysmenorrhea"},{"name":"Familial adenomatous polyposis (FAP)"}]},"trialDetails":[{"nctId":"NCT07351968","phase":"PHASE1","title":"A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2026-03-10","conditions":"Moderate Pain in Knee Osteoarthritis, Severe Pain in Knee Osteoarthritis","enrollment":200},{"nctId":"NCT06231758","phase":"PHASE3","title":"Metformin Safety and Efficacy in Osteoarthritis.","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2024-01-30","conditions":"Osteo Arthritis Knee","enrollment":70},{"nctId":"NCT03590821","phase":"EARLY_PHASE1","title":"Timed Aspirin Chronobiome Study","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2027-12","conditions":"Healthy","enrollment":60},{"nctId":"NCT05077332","phase":"PHASE2","title":"LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)","status":"COMPLETED","sponsor":"Leidos Life Sciences","startDate":"2021-12-29","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":4},{"nctId":"NCT07176533","phase":"NA","title":"Suprazygomatic Maxillary Nerve Block in Pediatric Tonsillectomy","status":"NOT_YET_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2026-01-01","conditions":"Tonsillitis","enrollment":60},{"nctId":"NCT06505187","phase":"PHASE2","title":"Celecoxib for ENT Pain Management","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2025-02-28","conditions":"Parotidectomy","enrollment":84},{"nctId":"NCT05357950","phase":"PHASE2","title":"A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS","status":"COMPLETED","sponsor":"NeuroSense Therapeutics Ltd.","startDate":"2022-05-31","conditions":"Amyotrophic Lateral Sclerosis, ALS","enrollment":69},{"nctId":"NCT05658887","phase":"PHASE4","title":"Preoperative Gabapentin vs Placebo for Vaginal Prolapse Surgery","status":"COMPLETED","sponsor":"Joseph Kowalski","startDate":"2023-01-01","conditions":"Pelvic Organ Prolapse, Perioperative/Postoperative Complications","enrollment":110},{"nctId":"NCT06159114","phase":"PHASE4","title":"Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS","status":"COMPLETED","sponsor":"Xintian Pharmaceutical","startDate":"2023-12-19","conditions":"Chronic Prostatitis","enrollment":246},{"nctId":"NCT07104266","phase":"PHASE2","title":"Triple Negative Breast Cancer and Celecoxib. Pilot Study","status":"RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2025-08-04","conditions":"Triple-Negative Breast Cancer","enrollment":30},{"nctId":"NCT06245109","phase":"PHASE4","title":"Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2024-02-26","conditions":"Knee Osteoarthritis","enrollment":180},{"nctId":"NCT03686657","phase":"PHASE1, PHASE2","title":"Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients","status":"NOT_YET_RECRUITING","sponsor":"ARKAY Therapeutics","startDate":"2025-10-10","conditions":"Type 2 Diabetes, High Blood Pressure, Arthritis","enrollment":115},{"nctId":"NCT06516094","phase":"PHASE3","title":"Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2024-04-11","conditions":"Chronic Low-back Pain","enrollment":192},{"nctId":"NCT04162873","phase":"PHASE2","title":"Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer","status":"TERMINATED","sponsor":"University of Utah","startDate":"2019-11-27","conditions":"Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Nasal Cavity and Paranasal Sinus Carcinoma","enrollment":13},{"nctId":"NCT06316843","phase":"PHASE2","title":"Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2","status":"COMPLETED","sponsor":"Bateman Horne Center","startDate":"2023-10-15","conditions":"Long COVID, PASC Post Acute Sequelae of COVID 19","enrollment":59},{"nctId":"NCT03090152","phase":"PHASE4","title":"Minimal Opioid Use After Total Hip Replacement (THR)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-03-08","conditions":"Osteoarthritis, Hip","enrollment":180},{"nctId":"NCT03084536","phase":"PHASE2","title":"PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-06-07","conditions":"Breast Cancer, Breast Cancer Female, Cancer of Breast","enrollment":134},{"nctId":"NCT03643744","phase":"PHASE1","title":"Photodynamic Therapy-Induced Immune Modulation: Part III","status":"TERMINATED","sponsor":"Wright State University","startDate":"2019-04-01","conditions":"Actinic Keratosis, Photodynamic Therapy","enrollment":12},{"nctId":"NCT04176419","phase":"PHASE3","title":"Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery","status":"TERMINATED","sponsor":"Case Comprehensive Cancer Center","startDate":"2020-01-17","conditions":"Postoperative Pain Control, Opioid Consumption","enrollment":30},{"nctId":"NCT04147013","phase":"PHASE4","title":"Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS","status":"ACTIVE_NOT_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2020-02-18","conditions":"Chronic Rhinosinusitis with Nasal Polyps, Aspirin-exacerbated Respiratory Disease","enrollment":44},{"nctId":"NCT04765644","phase":"PHASE4","title":"Arginine Supplementation to Improve Cardiovascular and Endothelial Function After NSAID Treatment","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2021-06-10","conditions":"Healthy","enrollment":44},{"nctId":"NCT00092768","phase":"PHASE3","title":"A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-03-01","conditions":"Osteoarthritis","enrollment":500},{"nctId":"NCT00092781","phase":"PHASE3","title":"A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-03-01","conditions":"Osteoarthritis","enrollment":500},{"nctId":"NCT05077969","phase":"PHASE2","title":"Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients","status":"TERMINATED","sponsor":"Leidos Life Sciences","startDate":"2021-12-29","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":4},{"nctId":"NCT01479829","phase":"PHASE4","title":"Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression","status":"COMPLETED","sponsor":"Loyola University","startDate":"2011-03-23","conditions":"Bipolar Depression","enrollment":100},{"nctId":"NCT04790812","phase":"PHASE4","title":"Preemptive Analgesia With Celecoxib for Acute Dental Pain Management","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-04-22","conditions":"Pain, Postoperative","enrollment":65},{"nctId":"NCT01344200","phase":"PHASE2","title":"CELECOXIB Plasma and Cerebral Spinal Fluid Pharmacokinetics in Children","status":"RECRUITING","sponsor":"Children's Hospital of Eastern Ontario","startDate":"2024-01-29","conditions":"Pharmacokinetics of Celecoxib in Children","enrollment":65},{"nctId":"NCT05288374","phase":"PHASE4","title":"Celecoxib in Postoperative Analgesia for Radius Fracture Surgery","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2022-02-10","conditions":"Pain, Postoperative","enrollment":42},{"nctId":"NCT06185543","phase":"PHASE2","title":"A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.","status":"UNKNOWN","sponsor":"NeuroSense Therapeutics Ltd.","startDate":"2023-11-19","conditions":"Alzheimer Disease","enrollment":20},{"nctId":"NCT02502006","phase":"PHASE1","title":"Variability in Response to Non-steroidal Anti-inflammatory Drugs","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2015-11","conditions":"Healthy","enrollment":16},{"nctId":"NCT02688400","phase":"PHASE3","title":"Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis","status":"COMPLETED","sponsor":"TRB Chemedica International SA","startDate":"2016-05","conditions":"Osteoarthritis, Osteoarthritis, Knee","enrollment":380},{"nctId":"NCT03949673","phase":"PHASE2","title":"Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip","status":"TERMINATED","sponsor":"Regeneron Pharmaceuticals","startDate":"2019-04-08","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip","enrollment":23},{"nctId":"NCT05085574","phase":"PHASE2","title":"Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)","status":"WITHDRAWN","sponsor":"Leidos Life Sciences","startDate":"2023-02-07","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":""},{"nctId":"NCT02389465","phase":"PHASE4","title":"Stress and Inflammation in Late-Life Depression","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2014-08","conditions":"Depression, Inflammation","enrollment":119},{"nctId":"NCT04648540","phase":"EARLY_PHASE1","title":"Multimodal Opioid-free Anesthesia Versus Opioid-based Anesthesia for Patients Undergoing Cardiac Valve Surgeries: RCT","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-12-01","conditions":"Anesthesia","enrollment":60},{"nctId":"NCT05555823","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect and DDI of Ascending Doses of the MEK Inhibitor Zapnometinib","status":"COMPLETED","sponsor":"Atriva Therapeutics GmbH","startDate":"2022-06-23","conditions":"Healthy","enrollment":96},{"nctId":"NCT05911126","phase":"NA","title":"How to Reduce Pain in Patients Undergoing Office Hysteroscopy.","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-06-13","conditions":"Pain","enrollment":180},{"nctId":"NCT05324163","phase":"PHASE3","title":"Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis","status":"COMPLETED","sponsor":"Jiangsu XinChen-Techfields Pharma Co., LTD.","startDate":"2021-09-29","conditions":"KNEE OSTEOARTHRITIS","enrollment":180},{"nctId":"NCT03304379","phase":"PHASE3","title":"Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2017-10-26","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip","enrollment":1650},{"nctId":"NCT01765296","phase":"PHASE3","title":"Phase III Study of CG100649 in Osteoarthritis Patients","status":"COMPLETED","sponsor":"CrystalGenomics, Inc.","startDate":"2013-03","conditions":"Localized Primary Osteoarthritis of Hip, Localized Primary Osteoarthritis of Knee","enrollment":362},{"nctId":"NCT03009019","phase":"PHASE3","title":"Efficacy, Tolerability, and Safety of DFN-15","status":"COMPLETED","sponsor":"BioDelivery Sciences International","startDate":"2016-12","conditions":"Migraine Headache","enrollment":631},{"nctId":"NCT03006276","phase":"PHASE3","title":"Efficacy, Tolerability, and Safety Study of DFN-15","status":"COMPLETED","sponsor":"BioDelivery Sciences International","startDate":"2016-12","conditions":"Migraine Headache","enrollment":622},{"nctId":"NCT04673578","phase":"PHASE2","title":"Adjunctive Celecoxib in Childhood-onset OCD Study","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2021-06-01","conditions":"Obsessive-Compulsive Disorder, Pediatric Psychiatric Disorder","enrollment":80},{"nctId":"NCT00194090","phase":"PHASE4","title":"Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2004-06","conditions":"Knee Osteoarthritis","enrollment":40},{"nctId":"NCT05509946","phase":"PHASE2, PHASE3","title":"Preemptive Analgesia Combination of Celecoxib and Pregabalin in THA","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2022-10-01","conditions":"Arthroplasty Complications, Analgetic, Celecoxib","enrollment":30},{"nctId":"NCT05362851","phase":"PHASE3","title":"Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee","status":"UNKNOWN","sponsor":"Yooyoung Pharmaceutical Co., Ltd.","startDate":"2021-11-11","conditions":"Osteoarthritis, Knee","enrollment":692},{"nctId":"NCT05324995","phase":"PHASE2","title":"Peri-Articular-Multimodal Drug and Oral Celecoxib in Management of Postoperative Pain of Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2021-01-01","conditions":"Postoperative Pain, Total Knee Arthroplasty","enrollment":146},{"nctId":"NCT01150045","phase":"PHASE3","title":"Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery","status":"UNKNOWN","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2010-06","conditions":"Colorectal Cancer","enrollment":2527},{"nctId":"NCT03031938","phase":"PHASE3","title":"Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies","status":"COMPLETED","sponsor":"Pfizer","startDate":"2017-11-03","conditions":"Osteoarthritis, Cancer Pain, Recurrent Low Back Pain","enrollment":4},{"nctId":"NCT00809354","phase":"PHASE3","title":"Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip","status":"TERMINATED","sponsor":"Pfizer","startDate":"2009-02-12","conditions":"Osteoarthritis, Arthritis","enrollment":2720},{"nctId":"NCT04447261","phase":"PHASE1","title":"A Study to Test How Well Different Doses of BI 1356225 Are Tolerated by Men and Women With Obesity or Overweight","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2020-06-30","conditions":"Obesity","enrollment":87},{"nctId":"NCT03850587","phase":"PHASE2","title":"Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Yooyoung Pharmaceutical Co., Ltd.","startDate":"2018-08-30","conditions":"Osteoarthritis, Knee","enrollment":261},{"nctId":"NCT00484718","phase":"PHASE4","title":"Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib.","status":"TERMINATED","sponsor":"Pfizer","startDate":"2008-01-17","conditions":"Osteoarthritis","enrollment":6},{"nctId":"NCT00139776","phase":"PHASE4","title":"Study Of \"Continuous Use\" Of Celecoxib Vs. \"Usual or Intermittent Use\"","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2005-07","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip","enrollment":875},{"nctId":"NCT00359151","phase":"PHASE4","title":"Celebrex Total Knee Arthroplasty Study","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-11","conditions":"Osteoarthritis, Pain","enrollment":22},{"nctId":"NCT00141154","phase":"PHASE3","title":"Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-10","conditions":"Low Back Pain","enrollment":1234},{"nctId":"NCT00346216","phase":"PHASE4","title":"Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-10-04","conditions":"Arthritis, Rheumatoid","enrollment":24081},{"nctId":"NCT00402987","phase":"PHASE3","title":"Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-12-04","conditions":"Pharyngitis","enrollment":269},{"nctId":"NCT00630929","phase":"PHASE4","title":"Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-01","conditions":"Osteoarthritis, Knee","enrollment":388},{"nctId":"NCT00633386","phase":"PHASE4","title":"Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-02","conditions":"Arthroscopy","enrollment":200},{"nctId":"NCT00633438","phase":"PHASE4","title":"Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-01","conditions":"Arthroscopy","enrollment":204},{"nctId":"NCT00620867","phase":"PHASE4","title":"Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2002-10","conditions":"Osteoarthritis, Knee","enrollment":393},{"nctId":"NCT00663767","phase":"PHASE2","title":"A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-04-07","conditions":"Dental Pain","enrollment":250},{"nctId":"NCT00640627","phase":"PHASE4","title":"Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-12","conditions":"Osteoarthritis, Knee","enrollment":380},{"nctId":"NCT00638807","phase":"PHASE4","title":"Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-12","conditions":"Osteoarthritis, Knee","enrollment":388},{"nctId":"NCT00643799","phase":"PHASE4","title":"Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee Osteoarthritis","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-03","conditions":"Osteoarthritis, Knee","enrollment":586},{"nctId":"NCT01062113","phase":"PHASE2","title":"Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2010-04","conditions":"Pain","enrollment":255},{"nctId":"NCT00994461","phase":"PHASE4","title":"Study Of Celecoxib In Healthy Subjects","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2009-11","conditions":"Healthy Volunteers","enrollment":190},{"nctId":"NCT01838044","phase":"PHASE4","title":"Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2013-10","conditions":"Chronic Low Back Pain With a Neuropathic Component","enrollment":180},{"nctId":"NCT03554772","phase":"PHASE2","title":"Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2018-06-19","conditions":"Acute Pain","enrollment":120},{"nctId":"NCT04718649","phase":"NA","title":"Effectiveness and Safety of Celecoxib (Celebrex 200 mg) Combined With Joins in the Treatment of Degenerative Knee Osteoarthritis: a Randomized Controlled Trial","status":"UNKNOWN","sponsor":"The Catholic University of Korea","startDate":"2021-01","conditions":"Osteoarthritis","enrollment":216},{"nctId":"NCT03672162","phase":"NA","title":"Preoperative Analgesia in Non-gynecological Cancerous Women Who Underwent Elective Total Abdominal Hysterectomy","status":"COMPLETED","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2019-02-01","conditions":"Total Abdominal Hysterectomy ,Pain , Acute Postoperative,Gabapentin , Celecoxib","enrollment":90},{"nctId":"NCT00033371","phase":"PHASE2","title":"Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2001-12-13","conditions":"Colorectal Cancer, Familial Adenomatous Polyposis","enrollment":205},{"nctId":"NCT02725411","phase":"PHASE3","title":"Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain","status":"COMPLETED","sponsor":"Pfizer","startDate":"2016-05-26","conditions":"Low Back Pain","enrollment":277},{"nctId":"NCT00062179","phase":"PHASE2","title":"Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2003-03","conditions":"Lung Cancer","enrollment":7},{"nctId":"NCT02674386","phase":"PHASE3","title":"Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement","status":"COMPLETED","sponsor":"Pfizer","startDate":"2016-08-23","conditions":"Osteoarthritis","enrollment":154},{"nctId":"NCT03570554","phase":"PHASE2","title":"A Pilot Study Assessing the Treatment Responsiveness of a Novel Osteoarthritis Stiffness Scale","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-06-29","conditions":"Osteoarthritis, Knee","enrollment":41},{"nctId":"NCT02934191","phase":"PHASE2","title":"Celecoxib After Tonsillectomy","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2016-06","conditions":"Tonsillectomy","enrollment":172},{"nctId":"NCT02780323","phase":"PHASE4","title":"Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2015-11-02","conditions":"Rheumatoid Arthritis","enrollment":119},{"nctId":"NCT02528188","phase":"PHASE3","title":"Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee","status":"COMPLETED","sponsor":"Pfizer","startDate":"2015-07-21","conditions":"Chronic Pain, Osteoarthritis, Hip, Osteoarthritis, Knee","enrollment":3021},{"nctId":"NCT04082715","phase":"PHASE2","title":"Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain Plasticity","status":"WITHDRAWN","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2019-10","conditions":"Chronic Back Pain","enrollment":""},{"nctId":"NCT02979197","phase":"PHASE3","title":"Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives","status":"COMPLETED","sponsor":"Kitov Pharma Ltd","startDate":"2016-11-03","conditions":"Hypertension","enrollment":105},{"nctId":"NCT01872910","phase":"PHASE2","title":"A Study of LY3023703 Testing Pain Relief After Wisdom Teeth Removal","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-06","conditions":"Acute Pain","enrollment":124},{"nctId":"NCT02192190","phase":"PHASE2","title":"A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain","status":"TERMINATED","sponsor":"Eli Lilly and Company","startDate":"2014-07","conditions":"Osteoarthritis, Knee","enrollment":268},{"nctId":"NCT04020588","phase":"PHASE4","title":"Anti-inflammatories and Adolescent Schizophrenia","status":"UNKNOWN","sponsor":"Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico","startDate":"2019-02-25","conditions":"Schizophrenia","enrollment":90},{"nctId":"NCT03523832","phase":"PHASE2","title":"Preemptive Analgesia in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Fakultas Kedokteran Universitas Indonesia","startDate":"2015-07-01","conditions":"Acute Pain","enrollment":30},{"nctId":"NCT02703363","phase":"PHASE3","title":"Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression","status":"COMPLETED","sponsor":"Pakistan Institute of Living and Learning","startDate":"2016-08","conditions":"Depression, Bipolar Disorder, Bipolar Depression","enrollment":265},{"nctId":"NCT02037165","phase":"PHASE1","title":"Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-01-21","conditions":"Healthy","enrollment":25},{"nctId":"NCT01449630","phase":"PHASE1","title":"A Study of LY3031207 in Healthy Subjects","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2011-10-24","conditions":"Healthy Volunteers","enrollment":29},{"nctId":"NCT01768520","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of Knee","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2012-07-02","conditions":"Knee Osteoarthritis","enrollment":338},{"nctId":"NCT01632566","phase":"PHASE1","title":"A Multiple-dose Study of LY3031207 in Healthy Participants","status":"TERMINATED","sponsor":"Eli Lilly and Company","startDate":"2012-06","conditions":"Healthy Volunteers","enrollment":39},{"nctId":"NCT01129245","phase":"NA","title":"The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2009-09","conditions":"Ovulation, Luteal Development","enrollment":20},{"nctId":"NCT01968070","phase":"PHASE1","title":"A Study of LY3127760 in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-10","conditions":"Healthy Volunteers","enrollment":80},{"nctId":"NCT02362529","phase":"EARLY_PHASE1","title":"Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2015-02","conditions":"Major Depressive Disorder","enrollment":115},{"nctId":"NCT02987920","phase":"PHASE4","title":"Dextromethorphan Use in Multimodal Analgesia Regimens for Total Knee Arthroplasty","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2017-01","conditions":"Pain, Postoperative","enrollment":23},{"nctId":"NCT02198924","phase":"PHASE4","title":"Efficacy and Safety of Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib in Osteoarthritis Patients","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2014-12","conditions":"Pain, Inflammation","enrollment":246},{"nctId":"NCT02084511","phase":"PHASE1","title":"Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-03","conditions":"Pain, Postoperative","enrollment":80},{"nctId":"NCT02827487","phase":"PHASE4","title":"Tramadol Versus Celecoxib in Reducing Pain Associated With IUD Insertion","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2016-07-01","conditions":"Pain","enrollment":210},{"nctId":"NCT03108482","phase":"PHASE3","title":"Co-crystal E-58425 vs Tramadol and Celecoxib for Moderate to Severe Acute Pain After Bunionectomy. Phase III Clinical Trial.","status":"COMPLETED","sponsor":"Esteve Pharmaceuticals, S.A.","startDate":"2017-03-14","conditions":"Acute Post-surgical Pain","enrollment":637},{"nctId":"NCT02759198","phase":"PHASE2","title":"A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2016-05-02","conditions":"Knee Osteoarthritis","enrollment":456}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":786,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo and celecoxib","genericName":"Placebo and celecoxib","companyName":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","companyId":"pfizer-s-upjohn-has-merged-with-mylan-to-form-viatris-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain. Used for Rheumatoid arthritis, Osteoarthritis, Acute pain.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}